MENDiP: Measurements of Overnight Penile Temperature to Evaluate Nocturnal Erection Detection in Patients With Absence of Erectile Functioning After Robot-assisted Radical Prostatectomy (MENDiP)

October 10, 2022 updated by: Hille Torenvlied, St. Antonius Hospital
Nocturnal erection detection with the outdated RigiScan is the golden standard for erectile dysfunction (ED) nature differentiation. The Staying Hot and Feeling Hot study have shown that nocturnal erection detection is feasible with patient-friendly overnight penile temperature measurements. The question has arisen whether the penile temperature methodology is also capable to detect the absence of nocturnal erections, which is essential for clinical implementation in erectile dysfunction diagnostics. The objective of the MENDiP-study is to determine the feasibility to detect the absence of nocturnal erections with overnight penile temperature sensors. Furthermore, the MENDiP study functions as a first pilot trial to investigate the effect of age on the penile temperature during nocturnal erections in test subjects with normal erectile functioning. This is done in an observational study with a longitudinal design in which pre- and postoperative ambulatory overnight measurements are performed in patients, aged 55 - 70 years with preoperative normal sexual functioning, undergoing a non- or unilateral nerve-sparing robot assisted radical prostatectomy.

Study Overview

Study Type

Observational

Enrollment (Anticipated)

15

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

    • Utrecht
      • Nieuwegein, Utrecht, Netherlands, 3435CM
        • St. Antonius Ziekenhuis
        • Contact:
        • Sub-Investigator:
          • Karlijn van Adrichem, BSc.
        • Principal Investigator:
          • Jack Beck, dr., MD

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

53 years to 68 years (Adult, Older Adult)

Accepts Healthy Volunteers

N/A

Genders Eligible for Study

Male

Sampling Method

Non-Probability Sample

Study Population

Fifteen patients, aged 55 - 70 years, who will undergo a non- or unilateral-nerve-sparing robot assisted radical prostatectomy will be included in case preoperative normal erectile functioning and postoperative complete impotence at three months after surgery.

Description

Inclusion Criteria:

  1. Preoperative measurement:

    • Aged 55 - 70 years
    • Prostatecancer patients undergoing a non-/unilateral-nerve-sparing radical prostatectomy (RARP)
    • Pre-operative IIEF-5 score > 21
  2. Postoperative measurement

    • Inclusion criteria of pre-operative measurement
    • Preoperative penile temperature increase during first nocturnal erection of minimally 0.4 degrees Celsius
    • Post-operative IIEF-5 score < 12 with absence of morning erections

Exclusion Criteria:

  • Test subjects who are unwilling to sign informed consent
  • Test subjects with erectile dysfunction before RARP (IIEF-5 score of below 22)
  • (History of) sickle cell aneamia, atherosclerosis and diabetes type I or II. These conditions might influence penile blood circulation and therefore the accuracy of the study outcomes.
  • (History of) REM-sleep behavior disorder or other sleep disorders such as restless legs syndrome, insomnia, and sleep apnea
  • Usage of sleeping pills or benzodiazepines.
  • Postoperative results will be excluded from the study in case of presence of nocturnal erections according to the RigiScan data.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Cohort
  • Time Perspectives: Cross-Sectional

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Group 1
Age 55 - 60 years
The Feeling Hot sensor is a proof-of-concept system, which can measure overnight penile, thigh and air temperature.
Group 2
Age 60 - 65 years
The Feeling Hot sensor is a proof-of-concept system, which can measure overnight penile, thigh and air temperature.
Group 3
Age 65 - 70 years
The Feeling Hot sensor is a proof-of-concept system, which can measure overnight penile, thigh and air temperature.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Detectability absence nocturnal erections
Time Frame: 9 hours
Visual detectability of the presence and absence of nocturnal erections in overnight penile temperature measurements
9 hours
Penile temperature REM-sleep
Time Frame: 9 hours
Maximal variation in penile temperature during REM-sleep in case of presence and absence of nocturnal erections
9 hours
Penile temperature nocturnal erection
Time Frame: 9 hours
Maximal variation in penile temperature during nocturnal erections in men aged 55 - 70 years
9 hours

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Demographic data
Time Frame: 1 year
age, BMI, surgeries, comorbidities (diabetes, hypertension, hyperlipidemia), medication, status of smoking and alcohol consumption
1 year

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Jack Beck, dr., MD, Urologist

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Anticipated)

January 18, 2023

Primary Completion (Anticipated)

June 30, 2023

Study Completion (Anticipated)

October 10, 2023

Study Registration Dates

First Submitted

October 10, 2022

First Submitted That Met QC Criteria

October 10, 2022

First Posted (Actual)

October 13, 2022

Study Record Updates

Last Update Posted (Actual)

October 13, 2022

Last Update Submitted That Met QC Criteria

October 10, 2022

Last Verified

October 1, 2022

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Erectile Dysfunction

Clinical Trials on Feeling Hot sensor

3
Subscribe